» Articles » PMID: 28160748

Resting-state EEG Gamma Power and Theta-gamma Coupling Enhancement Following High-frequency Left Dorsolateral Prefrontal RTMS in Patients with Depression

Overview
Publisher Elsevier
Specialties Neurology
Psychiatry
Date 2017 Feb 5
PMID 28160748
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We aimed to investigate neuromodulatory effects of high-frequency left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation (rTMS) on resting-state electroencephalography (EEG) and their clinical and cognitive correlates in patients with depression.

Methods: Thirty-one patients diagnosed with depression included in the present study. Resting-state gamma power and theta-gamma coupling (TGC) were calculated before and after a course of rTMS. We explored the relationship among gamma power, TGC, and clinical/cognitive outcomes as measured with the Hamilton Rating Scale for Depression (HAM-D), Beck Depression Inventory (BDI), and Wisconsin Card Sorting Test (WCST).

Results: Following rTMS, depressed patients demonstrated significant increases of resting gamma power at the F3 and F4 electrode sites and resting TGC at the C3 and T3 electrode sites. Furthermore, the increased gamma power at the F3 electrode site was significantly correlated with improved score on the HAM-D and BDI, while the increased TGC at the C3 electrode site was significantly correlated with reduced number of errors on the WCST.

Conclusion: Thus, resting-state gamma power and TGC may represent potential biomarkers of depression associated with therapeutic effects of rTMS.

Significance: Resting-state EEG may provide potential biomarkers related to therapeutic effects of rTMS.

Citing Articles

The effect of repetitive and Deep Transcranial Magnetic Stimulation on quantitative electroencephalography in major depressive disorder.

Ilhan R, Arikan M Front Psychiatry. 2025; 15():1473743.

PMID: 39834570 PMC: 11743562. DOI: 10.3389/fpsyt.2024.1473743.


Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study.

Schwartzmann B, Chatterjee R, Vaghei Y, Quilty L, Allen T, Arnott S Transl Psychiatry. 2024; 14(1):432.

PMID: 39396045 PMC: 11470922. DOI: 10.1038/s41398-024-03110-8.


Resting-State EEG Alterations of Practice-Related Spectral Activity and Connectivity Patterns in Depression.

Tatti E, Cinti A, Serbina A, Luciani A, DUrso G, Cacciola A Biomedicines. 2024; 12(9).

PMID: 39335567 PMC: 11428598. DOI: 10.3390/biomedicines12092054.


Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction.

Nikolova Y, Ruocco A, Felsky D, Lange S, Prevot T, Vieira E medRxiv. 2024; .

PMID: 39252904 PMC: 11383479. DOI: 10.1101/2024.08.30.24312806.


The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders.

Palmisano A, Pandit S, Smeralda C, Demchenko I, Rossi S, Battelli L Life (Basel). 2024; 14(5).

PMID: 38792599 PMC: 11122172. DOI: 10.3390/life14050578.